Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy

Satoshi Toyota, Masahiro Eriguchi, Shoko Hasegawa, Kenji Ueki, Yuta Matsukuma, akihiro tsuchimoto, Kiichiro Fujisaki, kumiko torisu, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono

研究成果: ジャーナルへの寄稿記事

抄録

Patients with anti-glomerular basement membrane (GBM) antibody glomerulonephritis typically exhibit rapidly progressive glomerulonephritis (RPGN). The renal outcome as well as the prognosis of this disease is worse than other forms of RPGN such as those from microscopic polyangiitis. Therefore, early therapeutic intervention is essential to improve its prognosis. One month before referral to our hospital, a 54-year-old female attended another hospital because of macrohematuria. At that time, she had proteinuria and macrohematuria with normal renal function, was negative for anti-GBM antibodies, and was diagnosed with chronic glomerulonephritis. A month later when she was admitted to our hospital, she showed renal insufficiency and was positive for anti-GBM antibodies. Immediately after recognizing the anti-GBM antibody status, plasma exchange and the first course of steroid pulse therapy was started. After 5 days of therapy, renal biopsy confirmed severe crescentic glomerulonephritis in which all the observed glomeruli were involved with cellular crescents. Despite this, she survived without end-stage renal disease after three courses of steroid pulse therapy and seven sessions of plasma exchange. This favorable outcome reflects the repeated analysis of anti-GBM antibodies within a very short period and the rapid therapeutic intervention in addition to the intensive immunosuppressive therapies.

元の言語英語
ページ(範囲)25-32
ページ数8
ジャーナルCase Reports in Nephrology and Dialysis
9
発行部数1
DOI
出版物ステータス出版済み - 1 1 2019

Fingerprint

Glomerular Basement Membrane
Glomerulonephritis
Steroids
Antibodies
Plasma Exchange
Kidney
Therapeutics
Microscopic Polyangiitis
Immunosuppressive Agents
Proteinuria
Chronic Kidney Failure
Renal Insufficiency
Referral and Consultation
Biopsy

All Science Journal Classification (ASJC) codes

  • Nephrology

これを引用

Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy. / Toyota, Satoshi; Eriguchi, Masahiro; Hasegawa, Shoko; Ueki, Kenji; Matsukuma, Yuta; tsuchimoto, akihiro; Fujisaki, Kiichiro; torisu, kumiko; Tsuruya, Kazuhiko; Nakano, Toshiaki; Kitazono, Takanari.

:: Case Reports in Nephrology and Dialysis, 巻 9, 番号 1, 01.01.2019, p. 25-32.

研究成果: ジャーナルへの寄稿記事

@article{46764ebe5b584ab5915bdc88de5fd466,
title = "Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy",
abstract = "Patients with anti-glomerular basement membrane (GBM) antibody glomerulonephritis typically exhibit rapidly progressive glomerulonephritis (RPGN). The renal outcome as well as the prognosis of this disease is worse than other forms of RPGN such as those from microscopic polyangiitis. Therefore, early therapeutic intervention is essential to improve its prognosis. One month before referral to our hospital, a 54-year-old female attended another hospital because of macrohematuria. At that time, she had proteinuria and macrohematuria with normal renal function, was negative for anti-GBM antibodies, and was diagnosed with chronic glomerulonephritis. A month later when she was admitted to our hospital, she showed renal insufficiency and was positive for anti-GBM antibodies. Immediately after recognizing the anti-GBM antibody status, plasma exchange and the first course of steroid pulse therapy was started. After 5 days of therapy, renal biopsy confirmed severe crescentic glomerulonephritis in which all the observed glomeruli were involved with cellular crescents. Despite this, she survived without end-stage renal disease after three courses of steroid pulse therapy and seven sessions of plasma exchange. This favorable outcome reflects the repeated analysis of anti-GBM antibodies within a very short period and the rapid therapeutic intervention in addition to the intensive immunosuppressive therapies.",
author = "Satoshi Toyota and Masahiro Eriguchi and Shoko Hasegawa and Kenji Ueki and Yuta Matsukuma and akihiro tsuchimoto and Kiichiro Fujisaki and kumiko torisu and Kazuhiko Tsuruya and Toshiaki Nakano and Takanari Kitazono",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000499401",
language = "English",
volume = "9",
pages = "25--32",
journal = "Case Reports in Nephrology and Dialysis",
issn = "2296-9705",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy

AU - Toyota, Satoshi

AU - Eriguchi, Masahiro

AU - Hasegawa, Shoko

AU - Ueki, Kenji

AU - Matsukuma, Yuta

AU - tsuchimoto, akihiro

AU - Fujisaki, Kiichiro

AU - torisu, kumiko

AU - Tsuruya, Kazuhiko

AU - Nakano, Toshiaki

AU - Kitazono, Takanari

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients with anti-glomerular basement membrane (GBM) antibody glomerulonephritis typically exhibit rapidly progressive glomerulonephritis (RPGN). The renal outcome as well as the prognosis of this disease is worse than other forms of RPGN such as those from microscopic polyangiitis. Therefore, early therapeutic intervention is essential to improve its prognosis. One month before referral to our hospital, a 54-year-old female attended another hospital because of macrohematuria. At that time, she had proteinuria and macrohematuria with normal renal function, was negative for anti-GBM antibodies, and was diagnosed with chronic glomerulonephritis. A month later when she was admitted to our hospital, she showed renal insufficiency and was positive for anti-GBM antibodies. Immediately after recognizing the anti-GBM antibody status, plasma exchange and the first course of steroid pulse therapy was started. After 5 days of therapy, renal biopsy confirmed severe crescentic glomerulonephritis in which all the observed glomeruli were involved with cellular crescents. Despite this, she survived without end-stage renal disease after three courses of steroid pulse therapy and seven sessions of plasma exchange. This favorable outcome reflects the repeated analysis of anti-GBM antibodies within a very short period and the rapid therapeutic intervention in addition to the intensive immunosuppressive therapies.

AB - Patients with anti-glomerular basement membrane (GBM) antibody glomerulonephritis typically exhibit rapidly progressive glomerulonephritis (RPGN). The renal outcome as well as the prognosis of this disease is worse than other forms of RPGN such as those from microscopic polyangiitis. Therefore, early therapeutic intervention is essential to improve its prognosis. One month before referral to our hospital, a 54-year-old female attended another hospital because of macrohematuria. At that time, she had proteinuria and macrohematuria with normal renal function, was negative for anti-GBM antibodies, and was diagnosed with chronic glomerulonephritis. A month later when she was admitted to our hospital, she showed renal insufficiency and was positive for anti-GBM antibodies. Immediately after recognizing the anti-GBM antibody status, plasma exchange and the first course of steroid pulse therapy was started. After 5 days of therapy, renal biopsy confirmed severe crescentic glomerulonephritis in which all the observed glomeruli were involved with cellular crescents. Despite this, she survived without end-stage renal disease after three courses of steroid pulse therapy and seven sessions of plasma exchange. This favorable outcome reflects the repeated analysis of anti-GBM antibodies within a very short period and the rapid therapeutic intervention in addition to the intensive immunosuppressive therapies.

UR - http://www.scopus.com/inward/record.url?scp=85064933659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064933659&partnerID=8YFLogxK

U2 - 10.1159/000499401

DO - 10.1159/000499401

M3 - Article

AN - SCOPUS:85064933659

VL - 9

SP - 25

EP - 32

JO - Case Reports in Nephrology and Dialysis

JF - Case Reports in Nephrology and Dialysis

SN - 2296-9705

IS - 1

ER -